The RoadMap to Improve Drug Discovery
3D In Vitro Models
The technological advancement and the consequent emerging of 3D models offer more opportunities for pre-clinical therapies screening, in a way to envision precision and personalized medicine approaches.
Cellularis is working on the development of new bioengineering strategies for the construction of models to mimic several aspects of the tumor microenvironment components and dynamics.
Precision bioengineered in vitro 3D models recapitulate the hallmarks of human disease and impact therapies discovery pipeline
DESIGN PHASE
BIOENGINEERING PHASE
VALIDATION PHASE
Physiomimetic 3D model comprising tumor-stroma lung-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma pancreatic-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma breast-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma prostate-specific decellularized matrix
Physiomimetic 3D model comprising tumor-stroma glioblastoma-specific decellularized matrix